Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.
Posted on Sep 29, 2016
EDEN PRAIRIE, Minn., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that it is implementing a strategic realignment of its near term strategy to fully focus the Company's resources on its recently acquired Aquadex FlexFlow® System. The Aquadex system is ...
Posted on Sep 23, 2016
EDEN PRAIRIE, Minn., Sept. 23, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that on September 21, 2016, it received a letter from the Nasdaq Listing Qualifications Staff indicating that the Company did not timely demonstrate compliance with the $1.00 bid price require...
Posted on Aug 25, 2016
EDEN PRAIRIE, Minn., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on August 18, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved four equity awards, to be effective as of August 22...
Events & Presentations
Posted on Aug 24, 2016 at 11:45 AM CT
Posted on Aug 9, 2016 at 9:00 AM ET
Posted on May 26, 2016 at 3:30 AM CT